We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Dr. Olubukola Ayodele smiling next to the title of the presentation

Can Personalized Dosing Improve Life With Metastatic Breast Cancer?

Metastatic breast cancer care is increasingly focused on extending survival while preserving quality of life, yet treatment side effects and dosing variability remain major challenges in real-world practice. Differences in patient experience, especially across diverse populations, can make truly personalized treatment difficult to achieve.


In this Teach Me in 10, Dr. Olubukola Ayodele, a consultant medical oncologist at University Hospitals of Leicester, discusses a UK-wide study funded by Breast Cancer Now, the UK’s leading breast cancer charity. The study explores how diverse patients experience therapy side effects and whether personalized dosing could improve outcomes and care equity.


Watch this episode to discover: 

  • How treatment side effects impact daily life in metastatic breast cancer
  • Why personalized dosing is gaining attention in oncology care
  • How real-world evidence can improve equity and treatment decisions

Further resources: